US2005148620A1PendingUtilityA1

Sulfonamido ether substituted imidazoquinolines

Assignee: 3M INNOVATIVE PROPERTIES COPriority: Dec 8, 2000Filed: Feb 28, 2005Published: Jul 7, 2005
Est. expiryDec 8, 2020(expired)· nominal 20-yr term from priority
C07D 471/04A61P 31/12A61P 37/02
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims

exact text as granted — not AI-modified
1 - 26 . (canceled)  
     
     
         27 . A method of inducing cytokine biosynthesis in an animal comprising administering a compound selected from the group consisting of 
 N-(2-{2-[4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl]ethoxy}methylpropane-2-sulfonamide;    N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}methanesulfonamide;    N-{2-[2-(4-amino-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}methanesulfonamide; and    N-{2-[2-(4-amino-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}propane-2-sulfonamide;    or a pharmaceutically acceptable salt thereof, to the animal in an amount effective for cytokine induction.    
     
     
         28 . A method of treating a viral disease in an animal in need thereof comprising administering to the animal a therapeutically effective amount of a compound selected from the group consisting of 
 N-(2-{2-[4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl]ethoxy}ethyl)-N-methylpropane-2-sulfonamide;    N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}methanesulfonamide;    N-{2-[2-(4-amino-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}methanesulfonamide; and    N-{2-[2-(4-amino-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}propane-2-sulfonamide;    or a pharmaceutically acceptable salt thereof, that induces cytokine biosynthesis.

Join the waitlist — get patent alerts

Track US2005148620A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.